⚠️ Disclaimer

Pinealon is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

Russian research in 72+ patient cohorts demonstrates cognitive improvements after traumatic brain injury and age-related decline. Enhanced memory and emotional stability documented. Limited English-language literature. Pinealon is not fda-approved. used clinically in russia. research-only in us.

What Does the Research Say About Pinealon?

Russian research in 72+ patient cohorts demonstrates cognitive improvements after traumatic brain injury and age-related decline. Enhanced memory and emotional stability documented. Limited English-language literature.

Pinealon (Glu-Asp-Arg tripeptide (EDR)) is a Tripeptide geroprotector, neuropeptide. Research interest has focused on its potential effects on cognitive function improvement, neuroprotection, enhanced cerebellum protection, reduced brain cell apoptosis, emotional balance.

What Is the Evidence for Pinealon's Mechanism?

Activates gene expression and protein synthesis in neural tissues while reducing apoptosis. Displays neuroprotection through reduced oxidative stress, enhanced cerebellum neuron resistance, and improved mitochondrial function in aging brains.

These pathways have been identified through in vitro studies, animal models, and where available, human trials.

Are There Human Clinical Trials for Pinealon?

Russian research in 72+ patient cohorts demonstrates cognitive improvements after traumatic brain injury and age-related decline. Enhanced memory and emotional stability documented. Limited English-language literature.

The gap between preclinical promise and clinical validation remains the biggest challenge in peptide research. However, Pinealon has shown preliminary results.

What Does the Safety Research Show?

Generally well-tolerated. Potential injection site reactions, mild muscle aches, headache, transient lightheadedness.

Pinealon is not fda-approved. used clinically in russia. research-only in us.

What Makes Pinealon Unique in Research?

Pineal-selective tripeptide with demonstrated neuroprotection against both aging and trauma — one of the few peptides targeting the pineal gland specifically.

This differentiator is important because it means Pinealon fills a role that other compounds in its class may not fully replicate.

Bottom Line on Pinealon Research

The evidence base for Pinealon is growing. Key research areas include cognitive function improvement, neuroprotection, enhanced cerebellum protection, reduced brain cell apoptosis, emotional balance.

Stay current with PubMed searches for Pinealon for the latest publications.

Complete Guide

Pinealon : Benefits, Dosage, Side Effects & Research

Read the Full Guide →

Related Reading

Calculate Your Pinealon Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Pinealon.

Open Calculator →

Research-Grade Sourcing

If you're going to research Pinealon, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Ascension → Browse Pinealon

Particle → Browse Pinealon

Frequently Asked Questions

What is Pinealon?

Pinealon (Glu-Asp-Arg tripeptide (EDR)) is a Tripeptide geroprotector, neuropeptide. Synthetic tripeptide derived from pineal gland secretions; Russian-developed geroprotector. It is researched for cognitive function improvement, neuroprotection, enhanced cerebellum protection, reduced brain cell apoptosis, emotional balance.

What is the recommended Pinealon dosage?

Common dosages: 10-30 mcg daily administered once daily via subcutaneous injection. Cycle length: 5-10 day cycles, repeated with rest periods. Half-life: estimated 18-24 hours. Use our peptide calculator for exact reconstitution math.

What are the side effects of Pinealon?

Generally well-tolerated. Potential injection site reactions, mild muscle aches, headache, transient lightheadedness.

Is Pinealon safe?

Pinealon has shown a favorable safety profile in research. Not FDA-approved. Used clinically in Russia. Research-only in US. All research should follow appropriate safety protocols.